Triple Starr valve replacement.

Area of Science:

• Cardiovascular Surgery
• Cardiac Valve Disease
• Rheumatic Heart Disease

Background:

• Rheumatic heart disease frequently affects multiple heart valves.
• Surgical intervention is often necessary for severe triple valve disease.
• Previous studies explored cardiac transplantation as a treatment option.

Purpose of the Study:

• To evaluate the long-term outcomes of triple valve replacement in patients with rheumatic heart disease.
• To compare the efficacy of triple valve replacement with cardiac transplantation.

Main Methods:

• Retrospective analysis of nine patients undergoing triple valve replacement.
• Assessment of postoperative mortality and long-term patient survival.
• Clinical follow-up to determine functional status and quality of life.

Main Results:

• Three out of nine patients experienced mortality within the study period.
• Postoperative deaths were attributed to myocardial reserve and cerebral embolism.
• The majority of surviving patients demonstrated good recovery and led normal lives.

Conclusions:

• Triple valve replacement is a viable treatment for rheumatic triple valve disease.
• Long-term outcomes suggest potential advantages over cardiac transplantation.
• Further research is warranted to confirm these findings and optimize patient selection.